Participated · Equity · May 2024

Supervizor provides a plug-and-play financial Quality Assurance platform that combines ERP transactions and other data sources into a single universal accounting model, backed by AI-based algorithms and a library of millions of accounting patterns. The platform continuously monitors transactions, detects multiple types of anomalies, and helps prevent fraud, enabling finance, accounting, and compliance teams to build error-proof financial statements. Supervizor integrates with all major ERPs, is available on the SAP Store, and is distributed by Sage, and analyzes transactions against more than 350 controls. The company says it is trusted by over 70 global enterprises, including Michelin, IKEA, Lacoste, and others. Supervizor plans to use new funding to drive continued innovation of its audit analytics platform and expand go-to-market operations worldwide, with particular focus on growing its North American customer base. The company has been operating since 2016 and was recently recognized by the AICPA for inclusion in its 2024 Startup Accelerator cohort. Supervizor provides analysis services and automated accounting and operational data software that detects accounting errors and fraud to reduce the risk of tax adjustment. Its system integrates with existing ERP, accounting and regulatory software tools. The platform is used by more than 5,000 companies. The company is finalizing partnerships with major players including ERP publishers, investment funds, law firms focused on cost optimization, and tax lawyers. Supervizor is co-founded by Cyrille de Gastines and Alban Clot. It intends to use new funding to grow in France and accelerate expansion across Europe.

Participated · Series C · Dec 2023

Founded in 2016, Igloo develops a technology platform that embeds micro-insurance products into the digital customer journeys of e-commerce, fintech and other online partners. The company operates in eight Southeast Asian markets and has facilitated more than 600 million insurance policies to date. Beyond traditional cover, Igloo has moved into climate-resilience insurance, offering data-driven protection against floods, fires and extreme weather events. It recently formed a joint venture with Thailand’s JMT Network Service to launch a fully digital insurer, a blueprint it intends to replicate in Indonesia and the Philippines. Igloo positions itself as an enabler of affordable, retail-focused insurance, leveraging data and partnerships to widen access. Financially, the startup raised over US$26 million in December 2023 and has accumulated US$79.19 million in equity funding from investors such as Openspace Ventures, Cathay Innovations, Blue Orchard and FinnFund.

Participated · Series C · Nov 2023

Indy is an all-in-one accounting platform for freelancers based in Lyon, France. Its core feature is automated accounting and it offers services for company creation, tax preparation, invoicing, and quotes. The company plans to add business banking to its product suite. Founded in 2016 by Côme Fouques, Pablo Larvor, Romain Koenig, and Adrien Plat, Indy aims to simplify freelancers' daily administrative tasks. The platform's recent fundraising will support expanding its offerings and growing its market reach. Indy's stated mission is to support independents by providing a simple application adapted to their needs. Indy (ex-Georges.tech) provides accounting software that automates data collection, processing, and submission to tax authorities for self-employed professionals and small teams. Its product includes a live chat support feature with responses in about a minute. The company charges an annual subscription of €240 and currently serves roughly 40,000 clients. Indy was founded in 2016 and positions itself as an alternative to traditional accounting firms through continuous investment in automation. The startup plans to expand to the US after a year of product development and adaptation, targeting American independents (around 24 million) as a key market. Indy aims to support over 6 million self-employed professionals in the long term and to grow its Lyon-based team.

Participated · Series A · Mar 2023

Inato operates a two-sided technology platform that connects pharmaceutical sponsors with community research sites to make clinical trials more accessible, inclusive, and efficient. The platform enables community sites to more efficiently select the right trial opportunities and helps sponsors partner with a broader range of verified community research sites, with collaborative, evidence-based enrollment planning and ongoing support. Inato plans to use new funding to advance its diversity product to help sponsors meet new FDA requirements, invest in oncology-specific innovations to increase access to care, and further define and scale its data model to improve matching reliability. The company announced a $20 million Series A2 financing from existing and new investors. Launched in late 2020, Inato's platform has grown to include over 2,500 community research sites supporting more than 70 disease areas in over 60 countries and has partnerships with a third of the top 30 pharmaceutical companies. The company will also pursue international growth and hiring to support continued product innovation. Inato provides a platform for biopharmaceutical companies to increase the pool of available patients engaged in clinical trials by unlocking research site potential and matching the best sites for any given study. The platform also ensures that site partners in its network are delivering trials. To date, Inato has worked with more than 2,000 research sites across over 50 global trials and has been used by more than 3,500 doctors in 75 countries. The company is led by CEO Kourosh Davarpanah and a management team that includes William Pambrun, Pr. Philippe Ravaud, Chief Medical Officer Dr. Jean-David Zeitoun, and CSO Liz Beatty. Inato is based in Paris and also has offices in New York and London. The company raised $14M in Series A funding to support growth and product development. Inato offers an AI-based data collection and analysis tool for the pharmaceutical sector focused on site selection and patient recruitment. The system automates data structuring and analysis, cross-checks data sources, and provides insights to accelerate recruitment and reduce development costs. CEO Kourosh Davarpanah says the platform accounts for over 200,000 hospital departments, more than 1.2 million investigators, and experience across 900,000+ trials. The company notes big pharma spends about 15% of annual revenue on clinical trials and that a single trial can cost up to $500 million, underscoring the potential impact of better site and patient selection. Inato raised €1.3 million from Serena Capital, Fly Ventures, Kima Ventures, Bertrand Diard and Franck le Ouay. The raise is intended to make clinical trials more efficient.

Participated · Series B · Oct 2022

Jiko combines the protections of a regulated national bank with a modern technology stack that automatically invests deposits in U.S. Treasury bills, giving clients a safe, yield-generating alternative to traditional demand deposits. Its API-driven platform allows institutions to hold and move corporate cash, settle high-volume transactions in real time, and access liquidity 24/7. The company recently launched JikoNet, a continuous fiat-settlement network purpose-built for institutions that need round-the-clock U.S.-dollar transfers. Jiko’s privacy-first architecture minimizes counter-party risk while maintaining compliance through its broker-dealer, Jiko Securities, Inc., and its banking division, Jiko Bank. The model has attracted digital-asset firms that require faster, safer on- and off-ramps between fiat and crypto markets. Industry veteran Breanne Madigan has joined as Managing Director and Head of Digital Assets to accelerate penetration of the crypto and fintech sectors. Although the company did not disclose revenue or user figures, it highlighted growing institutional adoption through new partnerships with Coinbase, Crypto.com, Bitso, and Blockstream Capital Partners.